Clinical Studies with Low Molecular Weight Heparins in the Prevention and Treatment of Venous Thromboembolism
作者： M. SAMAMA , J. P. BOISSEL , S. COMBE-TAMZALI , A. LEIZOROVICZ
DOI: 10.1111/J.1749-6632.1989.TB22520.X
关键词: Internal medicine 、 Medicine 、 Gastroenterology 、 Venous thromboembolism
摘要:
harvard.edu
sci-hub.se 参考文章(31)
Andrè Planes, Nicole Vochelle, Frçngois Mazas, Christian Mansat, Jean Zucman, Alain Landais, Jean Claude Pascariello, Dan Weill, Butel Jean, Prevention of postoperative venous thrombosis: a randomized trial comparing unfractionated heparin with low molecular weight heparin in patients undergoing total hip replacement. Thrombosis and Haemostasis. ,vol. 60, pp. 407- 410 ,(1988) , 10.1055/S-0038-1646980
Göran Bratt, Eva Törnebohm, Staffan Granqvist, Wiveca Åberg, Dieter Lockner, A comparison between low molecular weight heparin (KABI 2165) and standard heparin in the intravenous treatment of deep venous thrombosis. Thrombosis and Haemostasis. ,vol. 54, pp. 813- 817 ,(1985) , 10.1055/S-0038-1660139
J P Caen, A randomized double-blind study between a low molecular weight heparin Kabi 2165 and standard heparin in the prevention of deep vein thrombosis in general surgery. A French multicenter trial. Thrombosis and Haemostasis. ,vol. 59, pp. 216- 220 ,(1988) , 10.1055/S-0038-1642757
CJ Carter, JG Kelton, J Hirsh, A Cerskus, AV Santos, M Gent, The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin in rabbits. Blood. ,vol. 59, pp. 1239- 1245 ,(1982) , 10.1182/BLOOD.V59.6.1239.1239
Alexander G.G. Turpie, Mark N. Levine, Jack Hirsh, Cedric J. Carter, Richard M. Jay, Peter J. Powers, Maureen Andrew, Russell D. Hull, Michael Gent, A Randomized Controlled Trial of a Low-Molecular-Weight Heparin (Enoxaparin) to Prevent Deep-Vein Thrombosis in Patients Undergoing Elective Hip Surgery New England Journal of Medicine. ,vol. 315, pp. 925- 929 ,(1986) , 10.1056/NEJM198610093151503
A. A. Sasahara, K. Koppenhagen, R. Häring, D. Welzel, H. Wolf, Low molecular weight heparin plus dihydroergotamine for prophylaxis of postoperative deep vein thrombosis. British Journal of Surgery. ,vol. 73, pp. 697- 700 ,(2005) , 10.1002/BJS.1800730906
B. Boneu, M.R. Buchanan, J.F. Cade, J. Van Ryn, F.F. Fernandez, F.A. Ofosu, J. Hirsh, Effects of heparin, its low molecular weight fractions and other glycosaminoglycans on thrombus growth Thrombosis Research. ,vol. 40, pp. 81- 89 ,(1985) , 10.1016/0049-3848(85)90352-4
R. Dahan, D. Houlbert, C. Caulin, E. Cuzin, C. Viltart, M. Woler, J.M. Segrestaa, Prevention of Deep Vein Thrombosis in Elderly Medical In-Patients by a Low Molecular Weight Heparin: A Randomized Double-Blind Trial Haemostasis. ,vol. 16, pp. 159- 164 ,(1986) , 10.1159/000215286
A. J. Torres, I. Landa, F. Hernández, J. M. Jover, A. Suárez, J. Arias, Rosa Cuberes, J. Santoyo, Rosa Fernández, J. Calleja, Elena Nisa, J. L. Rodriguez, E. Moreno, J. L. Balibrea, Somatostatin in the treatment of severe upper gastrointestinal bleeding: A multicentre controlled trial British Journal of Surgery. ,vol. 73, pp. 786- 789 ,(2005) , 10.1002/BJS.1800731009
GrahamA. Colditz, RebeccaL. Tuden, Gerry Oster, Rates of venous thrombosis after general surgery: combined results of randomised clinical trials. The Lancet. ,vol. 2, pp. 143- 146 ,(1986) , 10.1016/S0140-6736(86)91955-0